Bidirectional regulation of macrophage function by TGF-β

Bogdan, 1993, Modulation of macrophage function by Transforming growth factor β Interleukin-4 and Interleukin-10, Ann. NY Acad. Sci., 713, 10.1111/j.1749-6632.1993.tb35934.x

Wahl, 1992, Transforming Growth Factor Beta (TGF-β) in Inflammation a cause and a cure, J. Clin. Immunol., 12, 61, 10.1007/BF00918135

Mc Cartney-Francis, 1998, TGF-β A balancing act, Intern. Rev. Immunol., 16, 553, 10.3109/08830189809043009

Assoian, 1987, Expression and secretion of type beta transforming growth factor by activated human macrophages, Proc. Natl. Acad. Sci. USA, 84, 6020, 10.1073/pnas.84.17.6020

Wahl, 1990, Macrophage production of TGF-β and regulation by TGF-β, Ann. NY Acad. Sci., 593, 188, 10.1111/j.1749-6632.1990.tb16111.x

Mc Cartney-Francis, 1990, TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes, Growth Factors, 4, 27, 10.3109/08977199009011007

Tsunawaki, 1988, Deactivation of macrophages by transforming growth factor-β, Nature, 334, 260, 10.1038/334260a0

Massague, 1990, The transforming growth factor-β family, Annu. Rev. Cell Biol., 6, 597, 10.1146/annurev.cb.06.110190.003121

Letterio, 1998, Regulation of immune responses by TGF-β, Annu. Rev. Immunol., 16, 137, 10.1146/annurev.immunol.16.1.137

Mc Cartney-Francis, 1994, Transforming growth factor β a matter of life and death, J. Leukoc. Biol., 55, 401, 10.1002/jlb.55.3.401

Wahl, 1994, Transforming growth factor beta the good the bad and the ugly, J. Exp. M, 180, 1587, 10.1084/jem.180.5.1587

Sporn, 1990, The transforming growth factor-β past present and future, 1

Roberts, 1992, Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues, Mol. Reprod. Dev., 32, 91, 10.1002/mrd.1080320203

Assoian, 1983, Transforming growth factor beta in human platelets, J. Biol. Chem., 258, 7155, 10.1016/S0021-9258(18)32345-7

Grotendorst, 1989, Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils, J. Cell Physiol., 140, 396, 10.1002/jcp.1041400226

Jacobsen, 1993, TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells Differential effects of TGF-β1 and TGF-β3, J. Immunol., 151, 4534, 10.4049/jimmunol.151.9.4534

Ashcroft, 1997, Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels, Nat. M, 3, 1209, 10.1038/nm1197-1209

Wakefield, 1988, Latent transforming growth factor-β from human platelets, A high molecular weight complex containing precursor sequences, J. Biol. Chem., 263, 7646, 10.1016/S0021-9258(18)68547-3

Grainger, 1995, Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin, Nat. M, 1, 932, 10.1038/nm0995-932

Schultz-Cherry, 1993, Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism, J. Cell Biol., 122, 923, 10.1083/jcb.122.4.923

Harpel, 1992, Control of transforming growth factor-beta activity latency vs, activation, Prog. Growth Factor Res., 4, 321, 10.1016/0955-2235(92)90014-9

Barcellos-Hoff, 1994, Transforming growth factor-β activation in irradiated murine mammary gland, J. Clin. Invest., 93, 892, 10.1172/JCI117045

Nunes, 1995, Characterization of latent TGF-β activation by murine peritoneal macrophages, J. Immunol., 155, 1450, 10.4049/jimmunol.155.3.1450

Falcone, 1995, THP-1 macrophage membrane-bound plasmin activity is upregulated by transforming growth factor- beta 1 via increased expression of urokinase and the urokinase receptor, J. Cell Physiol., 164, 334, 10.1002/jcp.1041640214

Twardzik, 1990, γ-Interferon-induced activation of latent transforming growth factor-β by human monocytes, 276

Salomon, 1990, Gene expression in normal and doxorubicin-impaired wounds importance of transforming growth factor-beta, Surgery, 108, 318

Khalil, 1996, Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by alveolar macrophages after in vivo bleomycin injury, Am. J. Resp. Cell Mol. Biol., 15, 252, 10.1165/ajrcmb.15.2.8703482

Wahl, 1990, Antagonistic and agonistic effects of transforming growth factor-β and IL-1 in rheumatoid synovium, J. Immunol., 145, 2514, 10.4049/jimmunol.145.8.2514

Connor, 1989, Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye, J. Clin. Invest., 83, 1661, 10.1172/JCI114065

Champsi, 1995, Production of TNF-alpha IL-6 and TGF-β and expression of receptors for TNF-alpha and IL-6 during murine Mycobacterium avium infection, Immunology, 84, 549

Vodovotz, 1994, Control of nitric oxide synthase expression by transforming growth factor-beta implications for homeostasis, Prog. Growth Factor Res., 5, 341, 10.1016/0955-2235(94)00004-5

Barral, 1993, Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis, Proc. Natl. Acad. Sci. USA, 90, 3442, 10.1073/pnas.90.8.3442

Wrana, 1994, Mechanism of activation of the TGF-beta receptor, Nature, 370, 341, 10.1038/370341a0

Wieser, 1995, GS domain mutations that constitutively activate TβR-1 the downstream signalling component in the TGF-β receptor complex, EMBO J., 14, 2199, 10.1002/j.1460-2075.1995.tb07214.x

Baker, 1997, From receptor to nucleus the Smad pathway, Curr. Opin. Genet. Dev., 7, 467, 10.1016/S0959-437X(97)80072-X

Rodriguez, 1995, Cooperative binding of transforming growth factor (TGF)-β2 to the types I and II TGF-β receptors, J. Biol. Chem., 270, 15919, 10.1074/jbc.270.27.15919

Heldin, 1997, TGF-β signalling from cell membrane to nucleus through Smad proteins, Nature, 390, 465, 10.1038/37284

Yanagisawa, 1998, Induction of apoptosis by Smad3 and downregulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells, Oncogene, 17, 1743, 10.1038/sj.onc.1202052

Brandes, 1991, Modulation of monocyte type I TGF-β receptors by inflammatory stimuli, J. Biol. Chem., 266, 19697, 10.1016/S0021-9258(18)55048-1

Wahl, 1987, Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production, Proc. Natl. Acad. Sci. USA, 84, 5788, 10.1073/pnas.84.16.5788

Wiseman, 1988, Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity, Biochem. Biophys. Res. Commun., 157, 793, 10.1016/S0006-291X(88)80319-X

Pierce, 1989, Transforming growth factor β reverses the glucocorticoid-induced wound healing deficit in rats Possible regulation in macrophages by platelet-derived growth factor, Cell Biol., 86, 2229

Allen, 1990, Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta, J. Exp. M, 171, 231, 10.1084/jem.171.1.231

Luger, 1983, Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells, J. Immunol., 131, 816, 10.4049/jimmunol.131.2.816

Ignotz, 1989, Regulation of cell adhesion receptors by transforming growth factor-beta, Concomitant regulation of integrins that share a common beta 1 subunit, J. Biol. Chem., 264, 389, 10.1016/S0021-9258(17)31270-X

Wahl, 1993, TGF-β enhances integrin expression and Type IV collagenase secretion in human monocytes, Proc. Natl. Acad. Sci. USA, 90, 4577, 10.1073/pnas.90.10.4577

Bauvois, 1992, IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells, J. Immunol., 148, 3912, 10.4049/jimmunol.148.12.3912

Bauvois, 1996, TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma dependence on alpha 5 beta 1 and beta 2 integrins, Exp. Cell Res., 222, 201, 10.1006/excr.1996.0026

Kehrl, 1986, Production of transforming growth factor-β by human T lymphocytes and its potential role in the regulation of T cell growth, J. Exp. M, 163, 1037, 10.1084/jem.163.5.1037

Turner, 1990, Transforming growth factor β induces the production of interleukin 6 by human peripheral blood mononuclear cells, Cytokine, 2, 211, 10.1016/1043-4666(90)90018-O

Kulkarni, 1993, Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death, Proc. Natl. Acad. Sci. USA, 90, 770, 10.1073/pnas.90.2.770

Kulkarni, 1994, TGF-β1 knockout mice immune dysregulation and pathology, 749

Welch, 1990, Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta, J. Immunol., 144, 3444, 10.4049/jimmunol.144.9.3444

Phillips, 1991, Platelet-induced expression of Fc gamma RIII (CD16) on human monocytes, Eur. J. Immunol., 4, 895, 10.1002/eji.1830210406

Hogasen, 1995, Transforming growth factor beta modulates C3 and factor B biosynthesis and complement receptor 3 expression in cultured human monocytes, J. Leukoc. Biol., 57, 287, 10.1002/jlb.57.2.287

Kruger, 1996, Granulocyte-macrophage colony-stimulating factor antagonizes the transforming growth factor-beta-induced expression of Fc gamma RIII (CD16) on human monocytes, Immunology, 87, 162

Shah, 1992, Control of scarring in adult wounds by neutralising antibodies to transforming growth factor beta, Lancet, 339, 213, 10.1016/0140-6736(92)90009-R

Border, 1992, Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease, Nature, 360, 361, 10.1038/360361a0

Isaka, 1996, Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney, Nat. M, 2, 418, 10.1038/nm0496-418

Shah, 1994, Neutralizing antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents, J. Cell Sci., 107, 1137, 10.1242/jcs.107.5.1137

Whitby, 1991, Immunohistochemical localization of growth factors in fetal wound healing, Dev. Biol., 147, 207, 10.1016/S0012-1606(05)80018-1

Adzick, 1994, Cells matrix growth factors and the surgeon, The biology of scarless fetal wound repair, Ann. Surg., 220, 10, 10.1097/00000658-199407000-00003

Cowin, 1998, Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse, Dev. Dyn., 212, 385, 10.1002/(SICI)1097-0177(199807)212:3<385::AID-AJA6>3.0.CO;2-D

Frank, 1996, Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing, J. Biol. Chem., 271, 10188, 10.1074/jbc.271.17.10188

Kopp, 1996, Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease, Lab. Invest., 74, 991

Letterio, 1996, Transforming growth factor-β1-deficient mice identification of isoform-specific activities in vivo, J. Leuk. Biol., 59, 769, 10.1002/jlb.59.6.769

Gamble, 1993, Transforming growth factor-β inhibits E-selectin expression on human endothelial cells, J. Immunol., 150, 4494, 10.4049/jimmunol.150.10.4494

Lefer, 1993, Mechanism of the cardioprotective effect of transforming growth factor β1 in feline myocardial ischemia and reperfusion, Proc. Natl. Acad. Sci. USA, 90, 1018, 10.1073/pnas.90.3.1018

Hines, 1994, Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice, Proc. Natl. Acad. Sci. USA, 91, 5187, 10.1073/pnas.91.11.5187

Mc Cartney-Francis, 1996, Autoimmune Sjogren's-like lesions in salivary glands of TGF-β1-deficient mice are inhibited by adhesion-blocking peptides, J. Immunol., 157, 1306, 10.4049/jimmunol.157.3.1306

Diebold, 1995, Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated, Proc. Natl. Acad. Sci..USA, 92, 12215, 10.1073/pnas.92.26.12215

Kitamura, 1997, Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-β1, J. Immunol., 159, 1404, 10.4049/jimmunol.159.3.1404

Sherry, 1998, Induction of the chemokine β peptides MIP-1α and MIP-1β by lipopolysaccharide is differentially regulated by immunomodulatory cytokines γ-IFN, IL-10, IL-4 and TGF-β, Mol. M, 4, 648, 10.1007/BF03401925

Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF, J. Clin. Invest., 101, 890, 10.1172/JCI1112

Tracey, 1988, Cachectin/tumor necrosis factor induces cachexia anemia and inflammation, J. Exp. M, 167, 1211, 10.1084/jem.167.3.1211

Turner, 1991, Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta, Eur. J. Immunol., 21, 1635, 10.1002/eji.1830210708

Wahl, 1993, Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist, J. Immunol., 150, 3553, 10.4049/jimmunol.150.8.3553

Ohguchi, 1998, Activin A regulates the production of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells, J. Interferon Cytokine Res., 18, 491, 10.1089/jir.1998.18.491

Leveque, 1998, Regulation of interleukin 3 receptor a chain (IL-3Ra) on human monocytes by interleukin (IL)-4 IL-10 IL-13 and transforming growth factor β (TGF-β, Cytokine, 10, 487, 10.1006/cyto.1997.0324

Warwick-Davies, 1995, Selective deactivation of human monocyte functions by TGF-β, J. Immunol., 155, 3186, 10.4049/jimmunol.155.6.3186

Vodovotz, 1996, Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse, J. Exp. M, 183, 2337, 10.1084/jem.183.5.2337

Erwig, 1998, Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines, J. Immunol., 161, 1983, 10.4049/jimmunol.161.4.1983

Brandes, 1991, Transforming growth factor β1 suppresses acute and chronic arthritis in experimental animals, J. Clin. Invest., 87, 1108, 10.1172/JCI115073

Song, 1998, Plasmid DNA encoding transforming growth factor-beta 1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model, J. Clin. Invest., 101, 2615, 10.1172/JCI2480

Kuruvilla, 1991, Protective effects of transforming growth factor β1 on experimental autoimmune disease in mice, Proc. Natl. Acad. Sci. USA, 88, 2918, 10.1073/pnas.88.7.2918

Racke, 1991, Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β, J. Immunol., 146, 1792, 10.4049/jimmunol.146.9.3012

Border, 1990, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1, Nature, 360, 361, 10.1038/360361a0